| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.11▲ | 2.13▼ | 2.13▼ | 2.16▼ | 2.37▼ |
| MA10 | 2.12▲ | 2.13▼ | 2.12▲ | 2.25▼ | 1.84▲ |
| MA20 | 2.13▼ | 2.12▲ | 2.19▼ | 2.35▼ | 1.33▲ |
| MA50 | 2.13▼ | 2.17▼ | 2.21▼ | 1.72▲ | 1.18▲ |
| MA100 | 2.17▼ | 2.28▼ | 2.35▼ | 1.28▲ | 1.43▲ |
| MA200 | 2.19▼ | 2.39▼ | 2.23▼ | 1.18▲ | 9.30▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.002▲ | -0.002▼ | -0.083▼ | 0.148▲ |
| RSI | 48.857▼ | 44.738▼ | 44.652▼ | 50.028▲ | 67.190▲ |
| STOCH | 29.167 | 54.104 | 47.385 | 15.090▼ | 72.041 |
| WILL %R | -20.000▲ | -48.148 | -74.545 | -86.316▼ | -38.337 |
| CCI | -30.108 | -48.454 | -43.778 | -103.050▼ | 60.631 |
| RSI | $IMAB RSI(14) Crossed Above 50 | Set Alert |
|
Wednesday, July 09, 2025 04:20 AM
I-Mab (NASDAQ:IMAB) is one of the best-performing NASDAQ stocks according to analysts. On July 2, I-Mab announced the presentation of positive Phase 1b combination data for givastomig at the European ...
|
|
Monday, July 07, 2025 11:57 PM
I-Mab (NASDAQ:IMAB) is one of the best-performing NASDAQ stocks according to analysts.On July 2, I-Mab announced the presentation of positive Phase 1b combination data for givastomig at the ...
|
|
Monday, June 30, 2025 01:53 AM
The study showed a >95% technical success rate when used with brush biopsy samples, a less invasive alternative to forceps biopsy. With a U.S. clinical launch expected in the next 2–3 quarters, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 2.08 | 2.19 | 2.08 | 2.13 | 224,336 |
| 10/07/25 | 2.30 | 2.37 | 2.05 | 2.05 | 396,581 |
| 09/07/25 | 2.22 | 2.41 | 2.22 | 2.31 | 371,677 |
| 08/07/25 | 2.13 | 2.25 | 2.10 | 2.20 | 447,618 |
| 07/07/25 | 2.07 | 2.195 | 2.07 | 2.09 | 351,196 |
| 03/07/25 | 2.31 | 2.3676 | 2.1037 | 2.15 | 358,562 |
| 02/07/25 | 2.36 | 2.50 | 2.22 | 2.29 | 485,363 |
| 01/07/25 | 2.43 | 2.50 | 2.2402 | 2.34 | 456,704 |
| 30/06/25 | 2.74 | 2.74 | 2.34 | 2.42 | 592,235 |
| 27/06/25 | 2.12 | 2.85 | 2.09 | 2.57 | 2,591,441 |
|
|
||||
|
|
||||
|
|